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Abstract
Purpose Although widely used, there is a lack of evidence
concerning the diagnostic accuracy of C-reactive protein
(CRP) and white blood cell counts (WBCs) in the
postoperative period. The aim of this study was to evaluate
the diagnostic accuracy of CRP and WBCs in predicting
postoperative inflammatory complications after open
resection of colorectal cancer.
Methods In this retrospective study, clinical data and the
CRP and WBCs, routinely measured until postoperative
day 5 (POD 5), were available for 1,187 patients who
underwent colorectal cancer surgery between 1997 and
2009. Using the receiver-operating characteristic (ROC)
methodology, the diagnostic accuracy was evaluated
according to the area under the curve (AUC).
Results Three hundred forty-seven patients (29.2%; 95% CI,
26.7–31.9%) developed various inflammatory complications.
Anastomotic leakage occurred in 8.0% (95%CI, 6.1–9.1%) of
patients. The CRP level on POD 4 (AUC 0.76; 95% CI,
0.71–0.81) had the highest diagnostic accuracy for the early
detection of inflammatory complications. With a cutoff of
123 mg/l, the sensitivity was 0.66 (95% CI, 0.56–0.74), and
the specificity was 0.77 (95% CI, 0.71–0.82). The diagnostic
accuracy of the WBC was significantly lower compared to
CRP.
Conclusion Measurement of CRP on POD 4 is recommended
to screen for inflammatory complications. CRP values above
123 mg/l on POD 4 should raise suspicion of inflammatory
complications, although the discriminatory performance was
insufficient to provide a single threshold that could be used to
correctly predict inflammatory complications in clinical
practice. WBC measurement contributes little to the early
detection of inflammatory complications.
Registered at www.clinicaltrials.gov (NCT01221324)
Keywords C-reactive protein .White blood cell count .
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Introduction
Septic complications after colorectal resection for cancer
are observed in up to 40% [1, 2] of cases and consist
mainly of surgical site infections (up to 40%), pulmonary
infections (10%) and urinary infections (5%) [3]. Anasto-
motic leakage is the most feared complication after
colorectal cancer resection and is frequently diagnosed late
in the postoperative period, after a mean of 13 days [4].
Other inflammatory complications are diagnosed as late as
the ninth postoperative day [5]. Although measurements of
C-reactive protein (CRP) and white blood cell counts
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(WBCs) are performed extensively, there is still a lack of
evidence about their diagnostic value in predicting inflam-
matory complications, and the optimal timing for such
measurements after colorectal cancer surgery remains
unknown. It has been reported that for patients with
inflammatory complications after colorectal surgery,
pre-emptive antibiotic therapy may significantly improve
outcomes [6]. Furthermore, in sepsis, early goal-directed
therapy is essential in improving survival [7]. Therefore,
there is a need for the early detection of infectious
complications to facilitate the initiation of adequate
treatment as soon as possible. Although procalcitonin levels
seem to have a higher diagnostic accuracy than CRP in the
detection of inflammatory complications, CRP is the most
popular and most widely available marker of the acute
inflammatory response [6, 8, 9]. Peak serum levels of CRP
lag approximately 2 days behind the initiation of an acute
systemic inflammatory response, and its half-life of
approximately 19 h is short enough to establish CRP as a
valuable marker of inflammatory processes [10–12].
The literature on the diagnostic value of CRP and WBCs
after colorectal cancer surgery is limited. Based on small
heterogeneous patient groups, some studies failed to
demonstrate a relevant diagnostic value of CRP in the
detection of inflammatory complications [13]. Other studies
did not apply the statistically adequate receiver-operating
characteristic (ROC) analysis, probably because of the
small sample sizes [5, 14]. In other studies, CRP and
WBCs were examined only every other day [15]. One
recently published study examining a small cohort estimated
an optimal cut-off value of 145 mg/l for CRP on postoperative
day 4 (POD 4), which yielded a sensitivity of 0.85 and a
specificity of 0.86; the WBC was not assessed [16]. Other
studies focused on postoperative changes in CRP rather than
on absolute values and identified a lack of decline as a
prognostic marker of anastomotic leakage [17].
The present study aimed to assess the diagnostic
accuracy of absolute CRP and WBC values and their
dynamics in the early detection of inflammatory complica-
tions from POD 1 to POD 5 in a series of unselected
consecutive patients after colorectal cancer resection.
Patients and methods
The study design was retrospective. A computer search
of the institutional database identified a total of 1,238
patients with histologically proven colorectal adenocarci-
noma who underwent primary colorectal cancer resection
between January 1997 and August 2009. All patients
routinely received preoperative antibiotic prophylaxis
(500 mg metronidazole i.v. and 2,000 mg cefamandole
i.v. for 60 min before surgery) and anticoagulation with
low-molecular-weight heparin, in accordance with hospital
guidelines.
Data collection and definitions
Data on patient demographics, operative details, postoperative
mortality, morbidity and histological results were gathered
retrospectively from the medical records. Mortality was
defined as any death that occurred on or before the 30th
postoperative day. Anastomotic leakage was defined as the
presence of an intra-abdominal abscess with confirmation by
rectal examination, sigmoidoscopy, extravasation of endolu-
minally administered water-soluble contrast on radiography
or computed tomography or confirmation upon return to the
operating room. Wound infections and intra-abdominal
abscesses that were not related to anastomotic leakages were
recorded according to the diagnosis in the medical records or
operation protocols. Pneumonia was recorded when explicitly
stated as a diagnosis in the medical records or as a radiological
finding. Urinary infections, central line infections, Clostridium
difficile colitis, or other infections were recorded when
explicitly stated in the medical records or when there were
bacteriological findings, independent of treatment.
CRP and WBC measurement
CRP concentrations were measured using an automated
analytical system (Unicel DxC 800, Beckman Coulter,
reference range <8 mg/l). WBCs were performed using an
automated haematology analyzer (Sysmex XE-5,000,
reference range 4–10 G/l). For CRP, the range of measure-
ment was limited to between 3 and 300 mg/l until August
2005. Subsequent to that, the measurement range was
extended to between 1 and 500 mg/l. Therefore, all CRP
values exceeding 300 mg/l were designated as 300 mg/l,
and values lower that 3 mg/l were designated as 3 mg/l.
Statistical analysis and authorization
Statistical analysis was performed using the R environment
(http://www.rproject.org). Two-sided p values <0.05 were
considered statistically significant. Continuous data are
expressed as the mean±standard deviation or interquartile
range (IQR), as appropriate. Confidence intervals (95% CI)
of binominal proportions were estimated according to a
modified Wilson's method [18].
The diagnostic accuracy was evaluated with the area
under the curve (AUC), using the ROC methodology [19].
The AUCs were computed using the non-parametric
trapezoidal method, and their 95% confidence limits were
computed according to method established by DeLong
[20]. Cut-off values were estimated by optimizing the
Youden index. Nonparametric 95% CIs for the cut-off
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values were computed with bootstrapping using the
percentile method (1,999 estimates) [21, 22].
The study was approved by the Swiss Federal Expert
Commission for Physician Confidentiality and by the
institutional ethical review board. It was registered at
www.clinicaltrials.gov (NCT01221324).
Results
Exclusion criteria, baseline and outcomes
For all 1,238 patients with open colorectal cancer resection,
clinical follow-up data for a minimum of 2 months were
available. Of these patients, 51 were excluded from further
analysis because of a lack of CRP and WBC measurements
until POD 5. Thus, 1,187 patients were available for further
analysis. Compared to the included patients, the excluded
patients developed pneumonia less often (3.9% versus
10.2%, p=0.001), resulting in significantly fewer inflam-
matory complications (23.5% versus 29.2%, p=0.024)
(Table 1).
Of the 1,187 patients, 26 died (2.2%; 95% CI,
1.5–3.2%). Inflammatory complications occurred in 347
patients (29.2%; 95% CI, 26.7–31.9%), and anastomotic
leakage occurred in 89 of the 1,115 patients who received
anastomoses (8.0%; 95% CI, 6.1–9.1%). Leakage was
diagnosed after a median of 9.0 days postoperatively
(IQR, 6–14 days). Patients with inflammatory complica-
tions presented with significantly higher ASA stages,
showed a significantly higher prevalence of rectal cancer
and received stomas more frequently (Table 2).
Postoperative course of CRP and WBCs
A total of 951 patients (80.1%) had 2.0±1.0 CRP measure-
ments through POD 5, and 1,183 (99.7%) had 2.8±1.2
WBC measurements through POD 5. Table 3 compares the
CRP and WBC values from patients with and without
inflammatory complications. In both groups, the highest
CRP and WBC values occurred on POD 2. Patients with
inflammatory complications had significantly higher CRP
values on POD 2 to POD 5. WBC values were significantly
higher in patients with inflammatory complications at every
time-point except on POD 2.
Diagnostic accuracy of absolute values of CRP and WBCs
Figure 1 presents the ROC plots for the diagnostic accuracy
of CRP levels in predicting inflammatory complications
between POD 2 and POD 5. CRP measured on POD 4 had
the highest diagnostic accuracy. The intrinsic diagnostic
accuracy of CRP and WBC values for inflammatory
complications is shown in detail in Table 4. Compared to
the diagnostic accuracy of WBCs, CRP had a significantly
greater AUC on POD 2 (p=0.034), POD 3 (p=0.003) and
POD 4 (p<0.001), but not on POD 5 (p=0.415).
The highest diagnostic accuracy was observed for CRP
measured on POD 4, with an AUC of 0.76 (95% CI,
0.71–0.81). The statistically optimal cut-off value for CRP
to discriminate between patients with and without inflam-
matory complications on POD 4 was 123 mg/l (95% CI,
94–160 mg/l). Of 103 patients with inflammatory compli-
cations, 68 had CRP values above this cutoff, such that the
sensitivity was 0.66 (95% CI, 0.56–0.74). In 162 of 211
patients without inflammatory complications, CRP values
did not exceed 123 mg/l, yielding a specificity of 0.77
(95% CI, 0.71–0.82). In Fig. 2, the sensitivity and
specificity of CRP measurement on POD 4 in predicting
inflammatory complications are plotted over the entire
range of CRP measurements. The cut-off value for a
sensitivity of 90% was estimated to be 56 mg/l (95% CI,
42–70 mg/l); for a specificity of 90%, the cut-off value was
200 mg/l (95% CI, 151–243 mg/l).
Applying the cut-off value of 123 mg/l for CRP on POD
4, the positive predictive value (PPV) was 0.54 (95% CI,
0.48–0.59), and the negative predictive value (NPV) was
0.85 (95% CI, 0.80–0.88) after adjusting for the observed
prevalence of 29.2% in the entire study population. For an
NPV of 0.90, the corresponding cut-off value was 54 mg/l.
In 71 of 314 patients (22.6%), CRP on POD 4 did not
exceed this value. Seven of these patients were classified as
false negatives, but developed only less serious complica-
Table 1 Inflammatory complications in included and excluded
patients
Total
N=1,238
Included
N=1,187
Excluded
N=51
p valuea
Any infectious
complication
359 (29.0%) 347 (29.2%) 12 (23.5%) 0.024
Anastomotic
leakageb
91 (7.8%) 89 (8.0%) 2 (4.3%) 0.813
Deep abscessc 47 (3.8%) 46 (3.9%) 1 (2.0%) 0.504
Wound infection 78 (6.3%) 77 (6.5%) 1 (2.0%) 0.799
Pneumonia 126 (10.2%) 124 (10.4%) 2 (3.9%) 0.001
Urinary tract
infection
92 (7.4%) 87 (7.3%) 5 (9.8%) 0.733
Central line
infection
41 (3.3%) 39 (3.3%) 2 (3.9%) 0.574
Clostridium
difficile colitis
12 (1.0%) 12 (1.0%) 0 (0.0%) 0.591
Other infection d 18 (1.5%) 18 (1.5%) 0 (0.0%) 0.923
a Chi-squared test
b Analysis for anastomotic leakage limited to 1,162/1,115/47 patients
with anastomosis
c Not related to anastomosis
d Cholecystitis, pancreatitis, genital or facial infections
Int J Colorectal Dis (2011) 26:1405–1413 1407
tions such as pneumonia (N=4), urinary tract infections
(N=3) and a central line infection (N=1).
Diagnostic accuracy of increasing CRP and WBCs
In 55 patients, CRP was measured both on POD 3 and POD 4.
Increasing CRP values were observed in 9 of 29 patients with
inflammatory complications (sensitivity 0.31; 95% CI,
0.17–0.49) and in 1 of 26 patients without inflammatory
complications (specificity 0.96; 95% CI, 0.81–0.99). In 52
patients, CRP was measured both on POD 4 and POD 5.
Increasing CRP values were observed in 15 of 35
patients with inflammatory complications (sensitivity
0.43; 95% CI, 0.28–0.59) and in 1 of 17 patients without
Table 2 Baseline data and clinical outcomes
Total Inflammatory complications p value
N=1,187 Yes (N=347) No (N=840)
Age [years] 66.9±12.1 68.2±12.1 66.4±12.1 0.021a
Body mass index [kg/m2] 25.6±4.4 25.6±4.5 25.7±4.3 0.643a
Gender Male 729 (61.4%) 218 (62.8%) 511 (60.8%) 0.522b
Female 458 (38.6%) 129 (37.2%) 329 (39.2%)
ASA stage I 102 (8.6%) 22 (6.3%) 80 (9.5%) <0.001a,c
II 750 (63.2%) 204 (58.8%) 546 (65.0%)
III 312 (26.3%) 111 (32.0%) 201 (23.9%)
IV 19 (1.6%) 9 (2.6%) 10 (1.2%)
X 4 (0.3%) 1 (0.3%) 3 (0.4%)
Cancer Colon 650 (54.8%) 176 (50.7%) 474 (56.4%) 0.072b
Localization Rectal 537 (45.2%) 171 (49.3%) 366 (43.6%)
UICC stage I 244 (20.6%) 75 (21.6%) 169 (20.1%) 0.695a,c
II 324 (27.3%) 88 (25.4%) 236 (28.1%)
III 291 (24.5%) 83 (23.9%) 208 (24.8%)
IV 281 (23.7%) 94 (27.1%) 187 (22.3%)
X 30 (2.5%) 5 (1.4%) 25 (3%)
Main operation Ileocoecal resection 4 (0.3%) 0 (0.0%) 4 (0.5%) 0.019b
Right hemicolectomy 256 (21.6%) 72 (20.7%) 184 (21.9%)
Transverse colectomy 9 (0.8%) 4 (1.2%) 5 (0.6%)
Left hemicolectomy 71 (6.0%) 17 (4.9%) 54 (6.4%)
Anterior resection 296 (24.9%) 78 (22.5%) 218 (26.0%)
Low anterior resection 428 (36.1%) 135 (38.9%) 293 (34.9%)
Total colectomy 41 (3.5%) 14 (4.0%) 27 (3.2%)
Abdominoperineal resection 45 (3.8%) 22 (6.3%) 23 (2.7%)
Segmental resection 15 (1.3%) 3 (0.9%) 12 (1.4%)
Transanal resection 22 (1.9%) 2 (0.6%) 20 (2.4%)
Operation time [min] 159.4±72.1 169±78.2 155.4±69 0.011a
Ostomy No 795 (67.0%) 206 (59.4%) 589 (70.1%) <0.001b
Yes 392 (33.0%) 141 (40.6%) 251 (29.9%)
Surgery Elective 1,090 (91.8%) 315 (90.8%) 775 (92.3%) 0.396b
Urgency 97 (8.2%) 32 (9.2%) 65 (7.7%)
Additional operation No 894 (75.3%) 258 (74.4%) 636 (75.7%) 0.620b
Yes 293 (24.7%) 89 (25.6%) 204 (24.3%)
Re-intervention w/in 30 days No 1,018 (85.8%) 237 (68.3%) 781 (93.0%) <0.001b
Yes 151 (12.7%) 110 (31.7%) 41 (4.9%)
Mortality w/in 30 days No 1,157 (97.5%) 330 (95.1%) 827 (98.5%) <0.001b
Yes 26 (2.2%) 17 (4.9%) 9 (1.1%)
Hospitalisation [days] 20.7±12.2 27.9±16.4 17.6±8.1 <0.001a
aMann–Whitney test
b Chi-squared test
c Analysis without missing values
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inflammatory complications (specificity 0.94; 95% CI,
0.73–0.99). After adjusting for the prevalence of 29.2% in the
study population, increases in CRP between POD 4 and POD 5
were calculated to have a PPVof 0.75 (95% CI, 0.62–0.85) and
an NPVof 0.80 (95% CI, 0.67–0.89). Combining the results of
the CRP measurement on POD 4 and the increase in CRP from
POD 4 to POD 5 did not improve the diagnostic accuracy,
regardless of whether the ‘believe-the-positive’ or the ‘believe-
the-negative’ rule was applied [23].
In 115 patients, WBC measurements were available on
POD 3 and POD 4. Increases in theWBC occurred in 25 of 57
patients with inflammatory complications (sensitivity 0.44;
95% CI, 0.32–0.57) and in 18 of 58 patients without
inflammatory complications (specificity 0.69; 95% CI,
0.56–0.79). In 98 patients, WBCmeasurements were obtained
on both POD 4 and POD 5. Increasing WBC levels were
observed in 29 of 56 patients with inflammatory complica-
tions (sensitivity 0.52; 95% CI, 0.39–0.64) and in 19 of 42
patients without inflammatory complications (specificity
0.55; 95% CI, 0.40–0.69). The PPV was 0.32 (95% CI,
0.24–0.42), and the NPV was 0.73 (95% CI, 0.64–0.81).
Subgroup analysis for anastomotic leakage
In a subgroup analysis, the diagnostic accuracy of CRP and
WBC levels in predicting anastomotic leakage was
analysed in the 1,115 patients who received anastomoses.
Anastomotic leakage was highly correlated with other
inflammatory complications; 54 of 89 (60.7%; 95% CI,
50.3–70.2%) patients with anastomotic leakage developed
other inflammatory complications. The detailed results for
Table 3 Postoperative course of CRP and WBC
Total Inflammatory complications p valuea
Yes No
N Med (IQR) N Med (IQR) N Med (IQR)
CRP [mg/l]
Preoperatively 562 5.5 (3.0–21.0) 178 7.0 (3.0–36.0) 384 5.0 (3.0–17.0) 0.006
POD 1 131 97.0 (66.0–136.0) 47 105.0 (68.0–148.0) 84 94.5 (65.0–127.5) 0.283
POD 2 256 151.5 (105.5–213.5) 83 187.0 (118.0–248.0) 173 142.0 (96.5–194.5) <0.001
POD 3 237 141.0 (100.5–213.5) 91 190.0 (124.0–255.0) 146 123.0 (86.0–176.3) <0.001
POD 4 314 100.5 (52.0–163.8) 103 163.0 (102.0–270.0) 211 78.0 (43.0–120.0) <0.001
POD 5 298 69.0 (34.0–129.3) 112 94.5 (53.0–200.8) 186 56.5 (28.8–98.3) <0.001
WBC [G/l]
Preoperatively 821 6.5 (5.3–8.1) 247 6.9 (5.4–8.7) 574 6.4 (5.2–7.9) 0.031
POD 1 452 8.7 (6.9–10.8) 146 8.9 (7.8–11.3) 306 8.4 (6.8–10.6) 0.032
POD 2 568 8.5 (6.9–10.6) 174 9.1 (7.2–11.1) 394 8.3 (6.9–10.3) 0.025
POD 3 424 7.8 (6.3–10.4) 157 8.3 (6.7–11.3) 267 7.6 (6.2–9.5) 0.005
POD 4 458 7.1 (5.6–9.1) 140 7.6 (5.9–10.4) 318 6.9 (5.5–8.6) 0.005
POD 5 405 7.2 (5.6–9.6) 146 8.6 (6.7–11.2) 259 6.7 (5.3–8.7) <0.001
aMann–Whitney test
Fig. 1 Empirical ROC plots for diagnostic accuracy of CRP in
detecting inflammatory complications at POD 2 to POD 5. The curves
occur in pairs of sensitivity and false-positive rate (1-specificity) of
CRP on PODs 2–5 with AUCs of 0.64, 0.69, 0.76 and 0.67. A perfect
marker would have an ROC plot along the left side and the top of the
graph. CRP measured on POD 4 is superior to the other CRP
measurement. The ROC plot for CRP on POD 4 does not cross the
other plots. All ROC plots are above the diagonal line, which is
equivalent to classification due to chance with an AUC of 0.5
(‘chance diagonal’)
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the intrinsic diagnostic accuracy of CRP in detecting
anastomotic leakage are provided in Table 5. CRP levels
had a significant predictive value for anastomotic leakage
on POD 3 to POD 5, but WBC measurements had a
significant predictive value for anastomotic leakage on
POD 5 only. CRP levels had the highest diagnostic
accuracy on POD 4. Applying the cut-off value of
143 mg/l and adjusting for a prevalence of 8%, the PPV
on POD 4 was 0.19 (95% CI, 0.14–0.23), and the NPV was
0.97 (95% CI, 0.94–0.99). In Fig. 3, the sensitivity and
specificity of CRP measurement on POD 4 in detecting
anastomotic leakage are plotted over the entire range of
CRP values.
Discussion
The early identification of patients who are at risk for
inflammatory complications is undoubtedly of high clinical
value. The prevalence of inflammatory complications in
this study was as high as 29.2%, with an 8.0% prevalence
of anastomotic leakage. The mortality of 2.2% in this study
is comparable to the outcomes in other studies [24, 25], and
it was significantly higher among patients with inflammatory
complications. Consistent with previous reports, leakages
were diagnosed after a median of nine postoperative days
(IQR, 6–14 days) [4, 5]. As the main finding, CRP measured
on POD 4 was the only marker of inflammatory complica-
tions and anastomotic leakage that could be rated as
moderately accurate, with AUCs of 0.76 and 0.77, respec-
tively [26]. Two other studies found the highest diagnostic
accuracy of CRP to be obtained on POD 5, although one ofTa
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those studies did not assess CRP on POD 4 [15, 16]. The
AUCs were higher than in the present study; however, in one
study, patients who had undergone laparoscopic operations
were included [16], whereas the other study assessed a
heterogeneous patient cohort that included patients with
cancer, diverticulitis and Crohn's/ulcerative colitis [15].
Increasing CRP between POD 4 and POD 5 was not
sensitive for inflammatory complications, but it was
specific. This result is consistent with the findings of
another recent study that demonstrated a lack of CRP
decline as a strong prognostic marker of anastomotic
leakage; however, that study did not apply the statisti-
cally adequate ROC analysis [17]. In the present study,
WBC values did not contribute substantially to distin-
guishing between patients with and without inflammatory
complications. To our knowledge, there is no other study
that directly compares the diagnostic impact of CRP and
WBC in detecting inflammatory complications after
colorectal surgery.
To derive clinical decisions from CRP values, it is
important to know that sensitivity and specificity are
inversely related depending on the choice of the cut-off
value. Using the statistically estimated ‘optimal’ cut-off
value of 123 mg/l for CRP on POD 4, the sensitivity was
66%, and the specificity was 77% in predicting inflamma-
tory complications; this corresponds to a PPV of 54% and
an NPVof 85% after adjustment for a prevalence of 29.2%.
The maximal achievable PPV for CRP when applying
higher cut-off values was less than 70%. Therefore, the
diagnostic accuracy of an increased CRP was not
sufficiently high to rule in inflammatory complications in
clinical practice [27]. Thus, the present data do not supportTa
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Fig. 3 Sensitivity and specificity of CRP on POD 4 in detecting
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the initiation of pre-emptive antibiotic treatment based
solely on an elevated CRP on POD 4, as was proposed by
Chromik et al. for procalcitonin [6]. In contrast, postoperative
estimations of CRP are valuable in ruling out inflammatory
complications. For this aim, a clinically defined cut-off
value, and not the statistically estimated optimal value,
should be applied. To achieve an NPVof 90%, the necessary
cut-off value was 54 mg/l. Unfortunately, the evidence from
the present retrospective study is not sufficiently strong to
provide a distinct cut-off value with the necessary certainty.
Such a cutoff should be identified and proven in large
prospective studies, and the present results might serve as a
benchmark.
According to the present study, in patients with CRP
values exceeding 123 mg/l on POD 4, inflammatory
complications will develop in approximately every other
patient, and a higher CRP indicates a higher risk of
inflammatory complications. When in doubt, a urinalysis,
thoracic X-ray, ultrasound examination or even a CT scan
should be considered in addition to a careful clinical
examination. Clinical suspicion may likely arise from an
elevated CRP on POD 4, although CRP measurements
cannot be used to separate patients into diseased and non-
diseased groups; rather, CRP values must be interpreted in
the context of the whole clinical picture.
In the present study, 61% of the patients with anasto-
motic leakage developed other inflammatory complications.
Furthermore, CRP is not specific to a particular type of
inflammatory complication [12]. Therefore, it seems
questionable to use this marker to predict leakages if
patients with other inflammatory complications are considered
non-diseased. Nevertheless, when using a CRP of 143 mg/l on
POD 4 as the cut-off value, the NPV was as high as 97%, and
the PPV was 19%. With an NPVof 97%, the development of
anastomotic leakage can be ruled out when the CRP value on
POD 4 is 143 mg/l or less. PPV is too low to rule in
anastomotic leakage [27].
In contrast to most other studies, the overall median
hospital stay of 20.7±12.2 days in the present series reflects
the current hospital policy in Switzerland, where reimburse-
ment is not yet based on diagnosis-related groups (DRG).
Under the special circumstances of this diagnostic study, the
long hospital stay is an advantage because the detection rate
for complications may be higher. This hypothesis is high-
lighted by the wide range of complications identified in this
study. Implementation of DRG-based reimbursement and fast-
track surgery inevitably leads to shorter hospital stays. In such
a context, CRP screening on POD 4 might prevent the
discharge of patients who may have undetected inflammatory
complications.
In interpreting the findings of the present study, it is
important to consider that these results are limited to a
single centre cohort between 1997 and 2009. Due to the
difficulties associated with the retrospective design, this study
did not assess the timing of inflammatory complications,
except for anastomotic leakage. Various forms of biases are
likely to have occurred in the present study, and theymay have
affected the selection of patients and the diagnostic perfor-
mance. For instance, postoperative CRP measurements may
have influenced the application of diagnostic techniques for
detection of postoperative inflammatory complications. How-
ever, the retrospective study design allowed for the assessment
of a large cohort that was treated according to day-to-day
clinical practice. In light of the comparative effectiveness
research [28, 29] guidelines, the present study and its
clinically relevant approach may help clinicians with their
decisions about using CRP as a diagnostic marker in patients
who have undergone colorectal cancer resection.
Conclusion
Although the present study used a retrospective design, it
confirmed CRP, best measured on POD 4, as a moderately
accurate diagnostic marker in the prediction of postoperative
inflammatory complications, including anastomotic leakage.
CRP values should not be used as a ‘black-and-white’
decision criterion, as the diagnostic accuracy was insufficient
to provide a single threshold that performed sufficiently well
to correctly predict inflammatory complications in clinical
practice. Interpretation of CRP values must be considered
within the whole clinical scenario. Measurement of WBCs
contributes little to the early detection of inflammatory
complications. If postoperative CRP measurement is to be
considered as a routine screen for postoperative inflammatory
complications after colorectal cancer surgery, we recommend
performing this test on POD 4.
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